DNA content of nasopharyngeal carcinoma

An independent prognostic indicator

M. M. Hsu, C. R. Chiou, J. Y. Ko, T. S. Sheen, R. L. Hong, L. L. Ting

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

The purpose of this study was to examine whether tumor DNA content correlated with prognosis in nasopharyngeal carcinoma (NPC). DNA flow-cytometric analysis in fresh specimens of nasopharyngeal biopsy from 123 patients with clinical suspicion of NPC was collected initially. Histopathologic study and successful flow-cytometric analysis had 28 lymphoid hyperplasias and 87 NPCs. Seventeen NPC patients were treated elsewhere and were excluded. A total of 98 patients, including 28 lymphoid hyperplasias and 70 NPCs, formed the materials of this study. There were 34 (49%) diploid and 36 (51%) aneuploid in NPC patients. No lymphoid hyperplasias were aneuploid. The mean of S-phase fraction was higher in NPC than in lymphoid hyperplasia (P < .001), indicating higher cellular activity in NPC. DNA content failed to associate with age, gender, pathology, distant metastasis, and stage, indicating that DNA content was an independent prognostic indicator and possibly a clinical parameter. The log-rank test of overall survival curves was significant for stage (P = .002) and DNA ploidy (P = .042); it was almost significant for S-phase fraction (P = .057). Because the follow-up duration was not long enough, univariate and multivariate analysis were not significant for stage, ploidy, and S-phase fraction, except for distant metastasis. It is also most likely colinearity of clinical stage and distant metastasis that explained why clinical stage could not show significance in prognosis. Interestingly, the DNA content appeared to be a potential prognostic parameter in overall survival, although it was not statistically significant (P = .052). Our data suggested that NPC patients with aneuploid DNA and high S-phase fraction tend to have poor prognosis and should be treated more aggressively, even in the early stage of the disease.

Original languageEnglish
Pages (from-to)119-126
Number of pages8
JournalCancer Detection and Prevention
Volume24
Issue number2
Publication statusPublished - Jul 15 2000
Externally publishedYes

Fingerprint

S Phase
DNA
Hyperplasia
Aneuploidy
Ploidies
Neoplasm Metastasis
Survival
Nasopharyngeal carcinoma
Diploidy
Multivariate Analysis
Pathology
Biopsy
Neoplasms

Keywords

  • DNA ploidy
  • Flow cytometry
  • Nasopharyngeal carcinoma
  • Prognostic factor
  • S-phase fraction

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Hsu, M. M., Chiou, C. R., Ko, J. Y., Sheen, T. S., Hong, R. L., & Ting, L. L. (2000). DNA content of nasopharyngeal carcinoma: An independent prognostic indicator. Cancer Detection and Prevention, 24(2), 119-126.

DNA content of nasopharyngeal carcinoma : An independent prognostic indicator. / Hsu, M. M.; Chiou, C. R.; Ko, J. Y.; Sheen, T. S.; Hong, R. L.; Ting, L. L.

In: Cancer Detection and Prevention, Vol. 24, No. 2, 15.07.2000, p. 119-126.

Research output: Contribution to journalArticle

Hsu, MM, Chiou, CR, Ko, JY, Sheen, TS, Hong, RL & Ting, LL 2000, 'DNA content of nasopharyngeal carcinoma: An independent prognostic indicator', Cancer Detection and Prevention, vol. 24, no. 2, pp. 119-126.
Hsu, M. M. ; Chiou, C. R. ; Ko, J. Y. ; Sheen, T. S. ; Hong, R. L. ; Ting, L. L. / DNA content of nasopharyngeal carcinoma : An independent prognostic indicator. In: Cancer Detection and Prevention. 2000 ; Vol. 24, No. 2. pp. 119-126.
@article{5fafa4881cf149f3a1193fa5c0958933,
title = "DNA content of nasopharyngeal carcinoma: An independent prognostic indicator",
abstract = "The purpose of this study was to examine whether tumor DNA content correlated with prognosis in nasopharyngeal carcinoma (NPC). DNA flow-cytometric analysis in fresh specimens of nasopharyngeal biopsy from 123 patients with clinical suspicion of NPC was collected initially. Histopathologic study and successful flow-cytometric analysis had 28 lymphoid hyperplasias and 87 NPCs. Seventeen NPC patients were treated elsewhere and were excluded. A total of 98 patients, including 28 lymphoid hyperplasias and 70 NPCs, formed the materials of this study. There were 34 (49{\%}) diploid and 36 (51{\%}) aneuploid in NPC patients. No lymphoid hyperplasias were aneuploid. The mean of S-phase fraction was higher in NPC than in lymphoid hyperplasia (P < .001), indicating higher cellular activity in NPC. DNA content failed to associate with age, gender, pathology, distant metastasis, and stage, indicating that DNA content was an independent prognostic indicator and possibly a clinical parameter. The log-rank test of overall survival curves was significant for stage (P = .002) and DNA ploidy (P = .042); it was almost significant for S-phase fraction (P = .057). Because the follow-up duration was not long enough, univariate and multivariate analysis were not significant for stage, ploidy, and S-phase fraction, except for distant metastasis. It is also most likely colinearity of clinical stage and distant metastasis that explained why clinical stage could not show significance in prognosis. Interestingly, the DNA content appeared to be a potential prognostic parameter in overall survival, although it was not statistically significant (P = .052). Our data suggested that NPC patients with aneuploid DNA and high S-phase fraction tend to have poor prognosis and should be treated more aggressively, even in the early stage of the disease.",
keywords = "DNA ploidy, Flow cytometry, Nasopharyngeal carcinoma, Prognostic factor, S-phase fraction",
author = "Hsu, {M. M.} and Chiou, {C. R.} and Ko, {J. Y.} and Sheen, {T. S.} and Hong, {R. L.} and Ting, {L. L.}",
year = "2000",
month = "7",
day = "15",
language = "English",
volume = "24",
pages = "119--126",
journal = "Cancer Epidemiology",
issn = "1877-7821",
publisher = "Elsevier BV",
number = "2",

}

TY - JOUR

T1 - DNA content of nasopharyngeal carcinoma

T2 - An independent prognostic indicator

AU - Hsu, M. M.

AU - Chiou, C. R.

AU - Ko, J. Y.

AU - Sheen, T. S.

AU - Hong, R. L.

AU - Ting, L. L.

PY - 2000/7/15

Y1 - 2000/7/15

N2 - The purpose of this study was to examine whether tumor DNA content correlated with prognosis in nasopharyngeal carcinoma (NPC). DNA flow-cytometric analysis in fresh specimens of nasopharyngeal biopsy from 123 patients with clinical suspicion of NPC was collected initially. Histopathologic study and successful flow-cytometric analysis had 28 lymphoid hyperplasias and 87 NPCs. Seventeen NPC patients were treated elsewhere and were excluded. A total of 98 patients, including 28 lymphoid hyperplasias and 70 NPCs, formed the materials of this study. There were 34 (49%) diploid and 36 (51%) aneuploid in NPC patients. No lymphoid hyperplasias were aneuploid. The mean of S-phase fraction was higher in NPC than in lymphoid hyperplasia (P < .001), indicating higher cellular activity in NPC. DNA content failed to associate with age, gender, pathology, distant metastasis, and stage, indicating that DNA content was an independent prognostic indicator and possibly a clinical parameter. The log-rank test of overall survival curves was significant for stage (P = .002) and DNA ploidy (P = .042); it was almost significant for S-phase fraction (P = .057). Because the follow-up duration was not long enough, univariate and multivariate analysis were not significant for stage, ploidy, and S-phase fraction, except for distant metastasis. It is also most likely colinearity of clinical stage and distant metastasis that explained why clinical stage could not show significance in prognosis. Interestingly, the DNA content appeared to be a potential prognostic parameter in overall survival, although it was not statistically significant (P = .052). Our data suggested that NPC patients with aneuploid DNA and high S-phase fraction tend to have poor prognosis and should be treated more aggressively, even in the early stage of the disease.

AB - The purpose of this study was to examine whether tumor DNA content correlated with prognosis in nasopharyngeal carcinoma (NPC). DNA flow-cytometric analysis in fresh specimens of nasopharyngeal biopsy from 123 patients with clinical suspicion of NPC was collected initially. Histopathologic study and successful flow-cytometric analysis had 28 lymphoid hyperplasias and 87 NPCs. Seventeen NPC patients were treated elsewhere and were excluded. A total of 98 patients, including 28 lymphoid hyperplasias and 70 NPCs, formed the materials of this study. There were 34 (49%) diploid and 36 (51%) aneuploid in NPC patients. No lymphoid hyperplasias were aneuploid. The mean of S-phase fraction was higher in NPC than in lymphoid hyperplasia (P < .001), indicating higher cellular activity in NPC. DNA content failed to associate with age, gender, pathology, distant metastasis, and stage, indicating that DNA content was an independent prognostic indicator and possibly a clinical parameter. The log-rank test of overall survival curves was significant for stage (P = .002) and DNA ploidy (P = .042); it was almost significant for S-phase fraction (P = .057). Because the follow-up duration was not long enough, univariate and multivariate analysis were not significant for stage, ploidy, and S-phase fraction, except for distant metastasis. It is also most likely colinearity of clinical stage and distant metastasis that explained why clinical stage could not show significance in prognosis. Interestingly, the DNA content appeared to be a potential prognostic parameter in overall survival, although it was not statistically significant (P = .052). Our data suggested that NPC patients with aneuploid DNA and high S-phase fraction tend to have poor prognosis and should be treated more aggressively, even in the early stage of the disease.

KW - DNA ploidy

KW - Flow cytometry

KW - Nasopharyngeal carcinoma

KW - Prognostic factor

KW - S-phase fraction

UR - http://www.scopus.com/inward/record.url?scp=0033920030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033920030&partnerID=8YFLogxK

M3 - Article

VL - 24

SP - 119

EP - 126

JO - Cancer Epidemiology

JF - Cancer Epidemiology

SN - 1877-7821

IS - 2

ER -